These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36639017)

  • 1. Protective role of cezanne in doxorubicin-induced cardiotoxicity by inhibiting autophagy, apoptosis and oxidative stress.
    Zhang J; Zha Y; Jiao Y; Li Y; Zhang S
    Toxicology; 2023 Feb; 485():153426. PubMed ID: 36639017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
    Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
    Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT4 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the AKT/mTOR/Autophagy Pathway.
    He L; Wang J; Yang Y; Zou P; Xia Z; Li J
    Toxicology; 2022 Mar; 469():153119. PubMed ID: 35134463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
    Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
    Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway.
    Jiao Y; Li Y; Zhang J; Zhang S; Zha Y; Wang J
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis.
    Zhang P; Lu H; Wu Y; Lu D; Li C; Yang X; Chen Z; Qian J; Ge J
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
    Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
    Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalpol Inhibits Autophagy to Ameliorate Doxorubicin-Induced Cardiotoxicity via the AKT-mTOR Pathway.
    Liu B; Xie H; Du X; Zhou Y; Huang J
    Int Heart J; 2023; 64(5):910-917. PubMed ID: 37778994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effects of
    Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP
    Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis.
    Qin Y; Lv C; Zhang X; Ruan W; Xu X; Chen C; Wan X; Ji X; Zhou J; Lu L; Guo X
    Cardiovasc Ther; 2022; 2022():9926635. PubMed ID: 35169398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daidzein ameliorates doxorubicin-induced cardiac injury by inhibiting autophagy and apoptosis in rats.
    Wu J; Li K; Liu Y; Feng A; Liu C; Adu-Amankwaah J; Ji M; Ma Y; Hao Y; Bu H; Sun H
    Food Funct; 2023 Jan; 14(2):934-945. PubMed ID: 36541083
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity.
    Cao Y; Shen T; Huang X; Lin Y; Chen B; Pang J; Li G; Wang Q; Zohrabian S; Duan C; Ruan Y; Man Y; Wang S; Li J
    Oncotarget; 2017 Jan; 8(3):4837-4848. PubMed ID: 27902477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tirzepatide protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and inflammation via PI3K/Akt signaling.
    Chen L; Chen X; Ruan B; Yang H; Yu Y
    Peptides; 2024 Aug; 178():171245. PubMed ID: 38801993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gab1 Overexpression Alleviates Doxorubicin-Induced Cardiac Oxidative Stress, Inflammation, and Apoptosis Through PI3K/Akt Signaling Pathway.
    Zhang Z; Shen C; Wu N; Wang J; Du W; Chen X
    J Cardiovasc Pharmacol; 2022 Dec; 80(6):804-812. PubMed ID: 35856909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. By restoring autophagic flux and improving mitochondrial function, corosolic acid protects against Dox-induced cardiotoxicity.
    Che Y; Wang Z; Yuan Y; Zhou H; Wu H; Wang S; Tang Q
    Cell Biol Toxicol; 2022 Jun; 38(3):451-467. PubMed ID: 34296331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marein Alleviates Doxorubicin-Induced Cardiotoxicity through FAK/AKT Pathway Modulation while Potentiating its Anticancer Activity.
    Xu J; Lv M; Ni X
    Cardiovasc Toxicol; 2024 Aug; 24(8):818-835. PubMed ID: 38896162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of TRIM16 mitigates doxorubicin-induced cardiotoxicity by modulating TAK1 and YAP/Nrf2 pathways in mice.
    Guo X; Liu M; Han B; Zheng Y; Zhang K; Bao G; Gao C; Shi H; Sun Q; Zhao Z
    Biochem Pharmacol; 2024 Feb; 220():116009. PubMed ID: 38154547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms.
    Wu S; Lan J; Li L; Wang X; Tong M; Fu L; Zhang Y; Xu J; Chen X; Chen H; Li R; Wu Y; Xin J; Yan X; Li H; Xue K; Li X; Zhuo C; Jiang W
    Cell Biol Toxicol; 2023 Feb; 39(1):237-258. PubMed ID: 34713381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.